In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique

R. D'Amelio, P. Rossi, S. Le Moli, R. Ricci, S. Montano, F. Pallone

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The locomotor function of polymorphonuclear cells (cellular chemotaxis) and serum chemotactic activity (humoral chemotaxis) were studied in 51 patients with Crohn's disease using a method of migration under agarose gel. To study cellular chemotaxis, patient's polymorphonuclear cells were challenged against normal Zymosan activated serum and humoral chemotaxis was evaluated testing the patient's Zymosan activated serum against normal polymorphonuclear cells. Cellular chemotaxis in the Crohn's disease group was normal (although 30% of the 51 patients had migration values out of the normal range), while humoral chemotaxis was significantly lower in Crohn's disease patients than in the control group. However, the value of humoral chemotaxis in the group of Crohn's disease patients treated with steroids was lower than that of patients not treated, thus accounting for the low mean value observed in the Crohn's disease group as a whole. The present results suggest that a defective chemotactic response may occur in some Crohn's disease patients, particularly during steroid treatment. These findings might be related either to a defective generation of complement derived chemotactic factors or to the presence of circulating inhibitors.

Original languageEnglish
Pages (from-to)566-570
Number of pages5
JournalGut
Volume22
Issue number7
Publication statusPublished - 1981

Fingerprint

Chemotaxis
Crohn Disease
Sepharose
Gels
Zymosan
Serum
Steroids
In Vitro Techniques
Chemotactic Factors
Reference Values
Control Groups

ASJC Scopus subject areas

  • Gastroenterology

Cite this

D'Amelio, R., Rossi, P., Le Moli, S., Ricci, R., Montano, S., & Pallone, F. (1981). In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique. Gut, 22(7), 566-570.

In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique. / D'Amelio, R.; Rossi, P.; Le Moli, S.; Ricci, R.; Montano, S.; Pallone, F.

In: Gut, Vol. 22, No. 7, 1981, p. 566-570.

Research output: Contribution to journalArticle

D'Amelio, R, Rossi, P, Le Moli, S, Ricci, R, Montano, S & Pallone, F 1981, 'In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique', Gut, vol. 22, no. 7, pp. 566-570.
D'Amelio, R. ; Rossi, P. ; Le Moli, S. ; Ricci, R. ; Montano, S. ; Pallone, F. / In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique. In: Gut. 1981 ; Vol. 22, No. 7. pp. 566-570.
@article{e13b6399ce4b4798b3f9b695b33410cc,
title = "In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique",
abstract = "The locomotor function of polymorphonuclear cells (cellular chemotaxis) and serum chemotactic activity (humoral chemotaxis) were studied in 51 patients with Crohn's disease using a method of migration under agarose gel. To study cellular chemotaxis, patient's polymorphonuclear cells were challenged against normal Zymosan activated serum and humoral chemotaxis was evaluated testing the patient's Zymosan activated serum against normal polymorphonuclear cells. Cellular chemotaxis in the Crohn's disease group was normal (although 30{\%} of the 51 patients had migration values out of the normal range), while humoral chemotaxis was significantly lower in Crohn's disease patients than in the control group. However, the value of humoral chemotaxis in the group of Crohn's disease patients treated with steroids was lower than that of patients not treated, thus accounting for the low mean value observed in the Crohn's disease group as a whole. The present results suggest that a defective chemotactic response may occur in some Crohn's disease patients, particularly during steroid treatment. These findings might be related either to a defective generation of complement derived chemotactic factors or to the presence of circulating inhibitors.",
author = "R. D'Amelio and P. Rossi and {Le Moli}, S. and R. Ricci and S. Montano and F. Pallone",
year = "1981",
language = "English",
volume = "22",
pages = "566--570",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "7",

}

TY - JOUR

T1 - In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique

AU - D'Amelio, R.

AU - Rossi, P.

AU - Le Moli, S.

AU - Ricci, R.

AU - Montano, S.

AU - Pallone, F.

PY - 1981

Y1 - 1981

N2 - The locomotor function of polymorphonuclear cells (cellular chemotaxis) and serum chemotactic activity (humoral chemotaxis) were studied in 51 patients with Crohn's disease using a method of migration under agarose gel. To study cellular chemotaxis, patient's polymorphonuclear cells were challenged against normal Zymosan activated serum and humoral chemotaxis was evaluated testing the patient's Zymosan activated serum against normal polymorphonuclear cells. Cellular chemotaxis in the Crohn's disease group was normal (although 30% of the 51 patients had migration values out of the normal range), while humoral chemotaxis was significantly lower in Crohn's disease patients than in the control group. However, the value of humoral chemotaxis in the group of Crohn's disease patients treated with steroids was lower than that of patients not treated, thus accounting for the low mean value observed in the Crohn's disease group as a whole. The present results suggest that a defective chemotactic response may occur in some Crohn's disease patients, particularly during steroid treatment. These findings might be related either to a defective generation of complement derived chemotactic factors or to the presence of circulating inhibitors.

AB - The locomotor function of polymorphonuclear cells (cellular chemotaxis) and serum chemotactic activity (humoral chemotaxis) were studied in 51 patients with Crohn's disease using a method of migration under agarose gel. To study cellular chemotaxis, patient's polymorphonuclear cells were challenged against normal Zymosan activated serum and humoral chemotaxis was evaluated testing the patient's Zymosan activated serum against normal polymorphonuclear cells. Cellular chemotaxis in the Crohn's disease group was normal (although 30% of the 51 patients had migration values out of the normal range), while humoral chemotaxis was significantly lower in Crohn's disease patients than in the control group. However, the value of humoral chemotaxis in the group of Crohn's disease patients treated with steroids was lower than that of patients not treated, thus accounting for the low mean value observed in the Crohn's disease group as a whole. The present results suggest that a defective chemotactic response may occur in some Crohn's disease patients, particularly during steroid treatment. These findings might be related either to a defective generation of complement derived chemotactic factors or to the presence of circulating inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=0019513402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019513402&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 566

EP - 570

JO - Gut

JF - Gut

SN - 0017-5749

IS - 7

ER -